Ryvu Therapeutics Employee Directory

Biotechnology ResearchLesser Poland, Poland201-500 Employees

Ryvu Therapeutics is a clinical-stage biotechnology company focused on discovering and developing novel small molecule therapies for cancer. Its internally discovered pipeline explores diverse mechanisms informed by cancer biology, including kinase inhibition, synthetic lethality, and immuno-oncology approaches. Its lead programs include RVU120, a selective CDK8/CDK19 inhibitor in early clinical development for hematologic malignancies and solid tumors, and SEL24 (MEN1703), a dual PIM/FLT3 inhibitor licensed to Menarini currently in Phase II for AML. Ryvu has established partnerships with global companies including Merck, Menarini, Galapagos, Exelixis, and BioNTech. Founded in 2007 and headquartered in Kraków, Lesser Poland, the company is listed on the Warsaw Stock Exchange as part of the sWIG80 index; in 2025 it formed a strategic collaboration with BioNTech US Inc. to support trial site activation and patient recruitment for BioNTech's oncology therapies in Poland.

Find Ryvu Therapeutics employees' phone numbers or email addresses

Ryvu Therapeutics Global Highlights

Location
Employees

Europe
222

Minus sign iconPlus sign icon
  • Poland
    214
  • France
    2
  • Germany
    2
  • Serbia
    1
  • Ukraine
    1
  • Switzerland
    1
  • United Kingdom Of Great Britain And Northern Ireland
    1

North America
3

Minus sign iconPlus sign icon
  • United States Of America
    3

Asia
1

Minus sign iconPlus sign icon
  • Lebanon
    1

South America
1

Minus sign iconPlus sign icon
  • Brazil
    1

Ryvu Therapeutics's Leadership

  • Stylized image of a person
    P. P.
    Chief Executive Officer, Co-Founder
    Phone icon
  • Stylized image of a person
    K. B.
    Chief Scientific Officer, Executive Vice President
    Phone icon
  • Stylized image of a person
    H. N.
    Chief Medical Officer
    Phone icon
  • Stylized image of a person
    K. S.
    Chief Operating Officer, Management Board Member
    Phone icon
  • Stylized image of a person
    V. V.
    Chief Business Officer
    Phone icon
  • Stylized image of a person
    M. M.
    Head Of Translational Medicine
    Phone icon
  • Stylized image of a person
    S. C.
    Head Of Translational Immuno-Oncology Research
    Phone icon
  • Stylized image of a person
    A. M.
    Head Of In Vivo Research Department
    Phone icon

Ryvu Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Biotechnology
  • Program & Project Management
  • Purchasing
  • Entrepreneurship
  • Human Resources
  • Other
  • Business

Contact profiles from Ryvu Therapeutics

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    P. P.
    Chief Executive Officer, Co-Founder
    Phone icon
    Jun 03, 2026
  • Stylized image of a person
    K. B.
    Chief Scientific Officer, Executive Vice President
    Phone icon
    Apr 14, 2026
  • Stylized image of a person
    H. N.
    Chief Medical Officer
    Phone icon
    SwitzerlandBasel-City
    Apr 16, 2026
  • Stylized image of a person
    K. S.
    Chief Operating Officer, Management Board Member
    Phone icon
    PolandLesser Poland
    May 05, 2026
  • Stylized image of a person
    V. V.
    Chief Business Officer
    Phone icon
    United StatesNew York
    Jun 08, 2026
  • Stylized image of a person
    M. M.
    Head Of Translational Medicine
    Phone icon
    Apr 14, 2026
  • Stylized image of a person
    S. C.
    Head Of Translational Immuno-Oncology Research
    Phone icon
    Apr 13, 2026
  • Stylized image of a person
    A. M.
    Head Of In Vivo Research Department
    Phone icon
    Poland
    Jul 30, 2025
  • Stylized image of a person
    J. F.
    Head Of Compound Management
    Phone icon
    PolandLesser Poland Voivodeship
    Mar 28, 2026
  • Stylized image of a person
    A. S.
    Research Operations Director
    Phone icon
    PolandMałopolskie
    Apr 13, 2026

Frequently Asked Questions

What is Ryvu Therapeutics known for?

Minus sign iconPlus sign icon
Ryvu Therapeutics was founded in 2007 operates in the Biotechnology Research industry. The company's main headquarters is located in 2 Ul. Leona Henryka Sternbacha Kraków, Lesser Poland 30-394 Poland. Explore Ryvu Therapeutics's company overview page for more information.

What is Ryvu Therapeutics's most common email format?

Minus sign iconPlus sign icon
Ryvu Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Ryvu Therapeutics email formats with LeadIQ.

How many employees does Ryvu Therapeutics have currently?

Minus sign iconPlus sign icon
Ryvu Therapeutics has approximately 216 employees as of May 2026. These team members are located across 4 continents, including EuropeNorth AmericaAsia.

Who are Ryvu Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of May 2026, Ryvu Therapeutics's key employees include:

  • Chief Executive Officer, Co-Founder: P. P.
  • Chief Scientific Officer, Executive Vice President: K. B.
  • Chief Medical Officer: H. N.
  • Chief Operating Officer, Management Board Member: K. S.
  • Chief Business Officer: V. V.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.